Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research

Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research

Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research

Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research

Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research

Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research

Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research

Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research

Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research

Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research

Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research

Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research

Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research

Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research

Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Front Neuroendocrinol. 2024 Feb 16;73:101131. doi: 10.1016/j.yfrne.2024.101131. Online ahead of print.ABSTRACTThis systematic review and meta-analysis aimed to determine the association between the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and dementia onset as well as cognitive function in patients with diabetes mellitus. We comprehensively searched the MEDLINE, Embase, and CENTRAL databases to select relevant studies published up to August 2023. The use of SGLT-2 inhibitors significantly lowers dementia risk compared to SGLT-2i non-users (Hazard ratio: 0.68, 95 % CI: 0.50-0.92). Furthermore, our findings ...
Source: Frontiers in Neuroendocrinology - February 17, 2024 Category: Endocrinology Authors: Yea Jin Youn Seungyeon Kim Hyun-Jeong Jeong Young-Mi Ah Yun Mi Yu Source Type: research